David D. Meek - Jan 17, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
Chief Executive Officer, Director
Signature
/s/ Reena R. Desai, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Jan 17, 2023
Transactions value $
-$134,715
Form type
4
Date filed
1/19/2023, 08:45 AM
Previous filing
Dec 21, 2022
Next filing
Jan 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$135K -3.18K -4.89% $42.38 61.8K Jan 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022.